AN1 0.00% 0.8¢ anagenics limited

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-1209

  1. 1,612 Posts.
    lightbulb Created with Sketch. 409
    Unfortunately that is not an interpretation that you would be justified in making - the test result doesn't tell you whether your immunity is winning.

    Andrew, I think you're right in saying that in your Situation 3, those treating the patient may feel that a negative PCR and positive POCT make it more likely than not that the patient has had COVID-19 - if the symptoms had been very suggestive of COVID, such as loss of taste or smell. But they would be confident mainly because of those symptoms, not the POCT, I think.

    Given the prevalence of other cold and flu symptoms that are not caused by COVID, however, and the incidence of false positives with POCT, I don't think treating clinicians would be confident to make the diagnosis on POCT alone, with nonspecific symptoms.

    So in my view, the POCT adds a tiny piece to the clinical picture in this specific scenario, but not a lot. In Australia, this scenario - a COVID patient presenting more than 2 weeks after infection, with a suggestive history, no prior testing and now a negative PCR - would be very uncommon, because our contact tracing is so pro-active.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $225 28.15K

Buyers (Bids)

No. Vol. Price($)
1 95279 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 80000 1
View Market Depth
Last trade - 15.38pm 26/08/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.